Reply to: Correspondence on 'The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology'
- PMID: 33279257
- DOI: 10.1016/j.jhep.2020.11.012
Reply to: Correspondence on 'The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology'
Keywords: Acute complications; Chronic liver disease; Non-elective admission; Outcome; Risk factors.
Conflict of interest statement
Conflict of interest As described in the original paper. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.J Hepatol. 2020 Oct;73(4):842-854. doi: 10.1016/j.jhep.2020.06.013. Epub 2020 Jul 13. J Hepatol. 2020. PMID: 32673741
-
Pre-acute-on-chronic liver failure in hepatitis B-related patients.J Hepatol. 2021 Feb;74(2):479-480. doi: 10.1016/j.jhep.2020.09.001. Epub 2020 Dec 2. J Hepatol. 2021. PMID: 33279256 No abstract available.
-
PREDICTing acute-on-chronic liver failure in patients with acute decompensation.J Hepatol. 2021 Feb;74(2):478-479. doi: 10.1016/j.jhep.2020.08.031. Epub 2020 Dec 3. J Hepatol. 2021. PMID: 33279258 No abstract available.
Similar articles
-
Serum Ammonia is Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated Cirrhosis [corrected].J Clin Gastroenterol. 2016 Apr;50(4):345-50. doi: 10.1097/MCG.0000000000000443. J Clin Gastroenterol. 2016. PMID: 26565968
-
Reply to: "IgG, a novel predictor for acute-on-chronic liver failure and survival in patients with decompensated cirrhosis?".J Hepatol. 2021 Jul;75(1):231-232. doi: 10.1016/j.jhep.2021.03.015. Epub 2021 Mar 23. J Hepatol. 2021. PMID: 33771608 No abstract available.
-
Reply to: "Is obesity a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis?".J Hepatol. 2018 Sep;69(3):758. doi: 10.1016/j.jhep.2018.05.022. Epub 2018 May 31. J Hepatol. 2018. PMID: 29859853 No abstract available.
-
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):167-180. doi: 10.1038/s41575-020-00376-3. Epub 2020 Nov 30. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33257833 Review.
-
Acute on Chronic Liver Failure and Immune Dysfunction: A Mimic of Sepsis.Semin Respir Crit Care Med. 2018 Oct;39(5):588-597. doi: 10.1055/s-0038-1672201. Epub 2018 Nov 28. Semin Respir Crit Care Med. 2018. PMID: 30485889 Review.
Cited by
-
Impact of multidrug resistance on the management of bacterial infections in cirrhosis.World J Clin Cases. 2023 Jan 26;11(3):534-544. doi: 10.12998/wjcc.v11.i3.534. World J Clin Cases. 2023. PMID: 36793638 Free PMC article. Review.
-
Acute-on-chronic liver failure: a global disease.Gut. 2022 Jan;71(1):5-6. doi: 10.1136/gutjnl-2020-323973. Epub 2021 Feb 25. Gut. 2022. PMID: 33632711 Free PMC article. No abstract available.
-
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence.Hepatol Int. 2024 Jun;18(3):929-942. doi: 10.1007/s12072-023-10636-4. Epub 2024 Feb 8. Hepatol Int. 2024. PMID: 38332428 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources